Nextage Therapeutics Ltd

Tel Aviv Stock Exchange NXTG.TA

Nextage Therapeutics Ltd Operating Cash Flow for the year ending December 31, 2023: USD -622.98 K

Nextage Therapeutics Ltd Operating Cash Flow is USD -622.98 K for the year ending December 31, 2023, a 63.54% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Nextage Therapeutics Ltd Operating Cash Flow for the year ending December 31, 2022 was USD -1.71 M, a -120.37% change year over year.
  • Nextage Therapeutics Ltd Operating Cash Flow for the year ending December 31, 2021 was USD -775.26 K, a 65.31% change year over year.
  • Nextage Therapeutics Ltd Operating Cash Flow for the year ending December 31, 2020 was USD -2.23 M.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
SV Wall Street
Tel Aviv Stock Exchange: NXTG.TA

Nextage Therapeutics Ltd

CEO Mr. Abraham Dreazen
IPO Date Aug. 12, 2002
Location Israel
Headquarters Einstein St. Building 13B
Employees 42
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Glass Personal Care Pharmaceuticals Snack Foods
Description

Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.

StockViz Staff

February 5, 2025

Any question? Send us an email